Feed Preview

Going Viral

Diabetes Medical Devices

Diabetes Medical Devices diagram by undefined

This feed focuses on novel advances in medical devices used to manage type I diabetes, such as an artificial pancreas and insulin pumps.

Top 20 most recent papers
Scientific Reports

Kisspeptin-Activated Autophagy Independently Suppresses Non-Glucose-Stimulated Insulin Secretion from Pancreatic β-Cells

Scientific ReportsNovember 25, 2019
Chien HuangChih-Hsien Chiu
7
Diabetes Care

Dietary Patterns of Insulin Pump and Multiple Daily Injection Users During Type 1 Diabetes Pregnancy

Diabetes CareNovember 6, 2019
Sandra L NeohCONCEPTT Collaborative Group
3
Nature Communications

Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulation

Nature CommunicationsNovember 20, 2019
Qingsheng LiuMinglin Ma
3
Diabetes Technology & Therapeutics

IN SILICO TRIALS OF AN OPEN-SOURCE ANDROID-BASED ARTIFICIAL PANCREAS: A NEW PARADIGM TO TEST SAFETY AND EFFICACY OF DO-IT-YOURSELF SYSTEMS

Diabetes Technology & TherapeuticsNovember 26, 2019
Chiara ToffaninLenka Petruzelkova
Journal of Diabetes Science and Technology

Quantifying the Impact of Influenza Among Persons With Type 2 Diabetes Mellitus: A New Approach to Determine Medical and Physical Activity Impact

Journal of Diabetes Science and TechnologyNovember 20, 2019
Sandrine I SamsonAnne C Beal
2
Diabetes Technology & Therapeutics

Efficacy of intermittently scanned continuous glucose monitoring in the prevention of recurrent severe hypoglycemia

Diabetes Technology & TherapeuticsNovember 14, 2019
Timothy M. E DavisW Shuford Davis
19
The American Journal of Case Reports

Simultaneous Diagnosis of Emphysematous Osteomyelitis and Emphysematous Pyelonephritis in a Diabetic Patient

The American Journal of Case ReportsDecember 2, 2019
Fotios-Panagiotis TatakisMoyssis Lelekis
Diabetes, Obesity & Metabolism

Pharmacokinetic and Pharmacodynamic Bioequivalence of Proposed Biosimilar MYL-1501D With US and EU Insulin Glargine Formulations in Patients With Type 1 Diabetes Mellitus

Diabetes, Obesity & MetabolismNovember 13, 2019
Tim HeisePatrick Aubonnet
Diabetes, Obesity & Metabolism

Long-term Real-life Glycemic Outcomes with Hybrid Closed-Loop System when Compared with Sensor-Augmented Pump Therapy in Patients with Type 1 Diabetes

Diabetes, Obesity & MetabolismDecember 2, 2019
Halis Kaan Kaan AkturkJanet K Snell-Bergeon
BMJ Open

Effectiveness of different recruitment strategies in an RCT of a surgical device: experience from the Endobarrier trial

BMJ OpenNovember 14, 2019
Aruchuna RubanJulian P Teare
Diabetes, Obesity & Metabolism

Increased Proportion of Time in Hybrid Closed-Loop "Auto Mode" is Associated with Improved Glycemic Control for Adolescent and Young Adult Type 1 Diabetes Patients Using the MiniMed 670G Insulin Pump

Diabetes, Obesity & MetabolismNovember 10, 2019
Sara DuffusJustin M Gregory
6
The Journal of the Association of Physicians of India

Consensus Statement on Use of Ambulatory Glucose Profile in Patients with Type 2 Diabetes Mellitus Receiving Oral Antidiabetic Drugs

The Journal of the Association of Physicians of IndiaNovember 1, 2019
Ambika Gopalakrishnan UnnikrishnanMangesh Tiwaskar
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders

Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy

Diabetes Therapy : Research, Treatment and Education of Diabetes and Related DisordersNovember 23, 2019
Louis S MatzaKristina Secnik Boye
Diabetic Medicine : a Journal of the British Diabetic Association

Monetary reinforcement for self-monitoring of blood glucose among young people with type 1 diabetes: evaluating effects on psychosocial functioning

Diabetic Medicine : a Journal of the British Diabetic AssociationNovember 8, 2019
Jencia WongAsani H Seawell
3
PloS One

Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning

PloS OneDecember 2, 2019
Michael MayoRyan G Paul
BMJ Open

Effects of basic carbohydrate counting versus standard outpatient nutritional education (The BCC Study): study protocol for a randomised, parallel open-label, intervention study focusing on HbA1c and glucose variability in patients with type 2 diabetes

BMJ OpenNovember 21, 2019
Bettina EwersTina Vilsbøll
Trials

TRIal to slow the Progression Of Diabetes (TRIPOD): study protocol for a randomized controlled trial using wireless technology and incentives

TrialsNovember 28, 2019
Robyn Su May LimEric Andrew Finkelstein
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders

The Diagnostic Utility of VibraTip for Distal Symmetrical Polyneuropathy in Type 2 Diabetes Mellitus

Diabetes Therapy : Research, Treatment and Education of Diabetes and Related DisordersNovember 28, 2019
Nikolaos P PapanasEfstratios S Maltezos
BMC Cardiovascular Disorders

Harnessing technology and molecular analysis to understand the development of cardiovascular diseases in Asia: a prospective cohort study (SingHEART)

BMC Cardiovascular DisordersNovember 21, 2019
Jonathan Jiunn Liang YapKhung Keong Yeo
2
International Journal of Endocrinology

Use of FreeStyle Libre Flash Monitor Register in the Netherlands (FLARE-NL1): Patient Experiences, Satisfaction, and Cost Analysis

International Journal of EndocrinologyNovember 3, 2019
Marion J FokkertH J G Henk Bilo

See more papers from this feed

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

© 2019 Meta ULC. All rights reserved
/feed-previews/diabetes-medical-devices/0150bad1-6cac-4ce0-a9f0-08761f2d912e